ArticleCureus2025
Postoperative Recurrence in Allergic Fungal Rhinosinusitis: A Single Center Experience.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Allergic fungal rhinosinusitis (AFRS) is a chronic inflammatory condition of the sinonasal mucosa with a propensity for postoperative recurrence despite surgical intervention. Understanding the factors contributing to recurrence is crucial for optimizing treatment outcomes. Study aim This retrospective cohort study aimed to assess demographic, clinical, pathological, and procedural factors associated with postoperative recurrence in AFRS patients undergoing functional endoscopic sinus surgery (FESS). Methodology Medical charts of 76 AFRS patients who underwent FESS between January 2008 and August 2021 at Prince Sultan Military Medical City in Riyadh, Saudi Arabia, were reviewed. Demographic data, clinical characteristics, comorbidities, surgical complications, histopathological findings, and postoperative outcomes were analyzed. Statistical analysis included the chi-square test and t-test. Results Relapse was observed in 42 (55.3%) patients. Significant predictors of relapse included younger age (24 ± 9 years in relapsing patients vs. 37 ± 17 years in non-relapsing patients, p < 0.001*), shorter time from presentation to surgery (229.8 ± 303.3 days in relapsing patients vs. 883.9 ± 1145.9 days in non-relapsing patients, p = 0.001*), and certain presenting symptoms such as facial swelling (p < 0.001*). Positive intraoperative cultures were more common in relapsing patients (73.3% vs. 36.4%, p = 0.029), and orbital extension was significantly associated with relapse (73.1% vs. 26.9%, p = 0.024). Surgical complications were more frequent among relapsing patients, although not statistically significant (85.7% vs. 52.2%, p = 0.089). Conclusions Our study highlights the multifactorial nature of postoperative recurrence in AFRS. Younger age, shorter time from presentation to surgery, specific severe presenting symptoms, positive intraoperative cultures, and orbital extension are significantly associated with higher relapse rates in AFRS patients. These findings highlight the need for tailored management strategies to reduce relapse rates, including aggressive and prolonged medical therapy, comprehensive preoperative assessments, and meticulous surgical and postoperative care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.